Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meetingBoris Jülg, Bruce D. Walker, Lynda Dee et al.|The Lancet HIV|2019Cited by 206
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trialJean‐Michel Molina, Juergen Rockstroh, Anthony Rodgers et al.|The Lancet HIV|2018Cited by 145
<i>In Vivo</i> Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043Nannan Zhou, Pin‐Fang Lin, Beata Nowicka-Sans et al.|Antimicrobial Agents and Chemotherapy|2010Cited by 54
Metformin and Time to Sustained Recovery in Adults With COVID-19Carolyn T. Bramante, Shelley Brunson, Thomas G. Stewart et al.|JAMA Internal Medicine|2025Cited by 5